CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.

Perel, P; Al-Shahi Salman, R; Kawahara, T; Morris, Z; Prieto-Merino, D; Roberts, I; Sandercock, P; Shakur, H; Wardlaw, J; (2012) CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial. Health technology assessment (Winchester, England), 16 (13). iii-54. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta16130

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3310/hta16130

Abstract

Share

Download

Filename: FullReport-hta16130.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar